howclose.to
Biology · Updated July 2026Momentum · accelerating

How close are we to transplanting animal organs into people?Can animal organs save people on the transplant list?

or, simply: Can animal organs save people on the transplant list?or, precisely: How close are we to transplanting animal organs into people?

Gene-edited pig organs have kept people alive for months; the open question is whether they can replace human donors for years, not weeks.Thousands die waiting for organs. Gene-edited pig kidneys and hearts could close the gap — if they last.

We are here

Controlled trials, sparse outcomes — EXPAND targets 50 participants, but no cohort-level 24-week survival distribution has yet been posted; 271 days remains the completed record. Next up — EXPAND primary completion target (expected Oct 2028).

01 · Where we stand

Four tests between here and the goal

Each threshold is a falsifiable claim with a named next test. We move the meter only when a result is public.

Avoid immediate immune destructionSurvive the first attack✓ Achieved · Sep 2021
100%
Proven byA single-edit kidney functioned through NYU's 54-hour brain-dead-body study.
Replace dialysis in a living personGo home without dialysis✓ Achieved · Apr 2024
100%
Proven byRichard Slayman was discharged 18 days after transplant and lived 52 days with the graft.
Sustain one dialysis-free yearLast a full yearIn progress
74%
Next testPublish a verified 365-day graft-function result, including GFR, rejection episodes and immunosuppression.
Produce a survival distributionProve it across a groupEarly
10%
Next testThe six-person EXPAND cohort reaches at least 12 weeks and undergoes independent safety review, followed by 24-week endpoint reporting.
THRESHOLDS — Thresholds for Xenotransplant.
Scale
Dialysis-free functional pig-kidney graft survival in living recipients: linear scaleDialysis-free functional pig-kidney graft survival in living recipients over time, with measured values, projected values, and a goal at 365 days.050100150200250300350Dialysis-free functional pig-kidney graft survival in living recipients · daysYear202420252026GOAL 365 · Initial one-year durabilityRichard Slayman; 52 days with the transplant before recipient death: 52 days (2024)Richard Slayman; 52 days with the transplant before recipient deathLisa Pisano; graft explanted after hypotension-related damage: 47 days (2024)Lisa Pisano; graft explanted after hypotension-related damageTowana Looney; graft explanted after acute rejection: 130 days (2025)Towana Looney; graft explanted after acute rejectionTim Andrews; graft explanted after declining function: 271 days (2025)Tim Andrews; graft explanted after declining functionBill Stewart; at least 250 days and ongoing at the last public update (right-censored): 250 days (2026)Bill Stewart; at least 250 days and ongoing at the last public update (right-censored)~115 days to goal
NOTE — This carries forward the candidate node's recommended metric. Values are individual cases, not a survival curve: compassionate-use recipients differed sharply in illness, donor edits and immunosuppression. Stewart's 250-day point is a published minimum while ongoing, not a final outcome. The one-year line is an editorial near-term goal; the candidate node's ten-year mature benchmark is deliberately not plotted because it is aspirational, not a dated forecast. Brain-dead-body experiments are excluded because they cannot establish recipient survival or durable clinical independence from dialysis.
02 · How we got here

The record behind the verdict

Major events set large; context events set small but never hidden. Everything below the TODAY rule is a schedule, not a result.

190619621 event1 shown

Borrowed Organs, Blind Immunity

Borrowed Organs, Blind Immunity begins with first vascular organ attempts. The result established the next question for the field.

1906
First vascular organ attemptsExperiment
Mathieu Jaboulay attached pig and goat kidneys to two women; both grafts failed within days.
196319962 events0 shown

Primate Grafts and Rejection

Primate Grafts and Rejection moved the field from chimp kidneys reach nine months to baby fae survives 21 days. The results narrowed the next question without closing it.

1963
Chimp kidneys reach nine months
Reemtsma transplanted chimpanzee kidneys into 13 patients; one recipient returned to work and survived nearly 9 months.
199720143 events1 shown

Virus Risk Meets Gene Editing

Virus Risk Meets Gene Editing moved the field from pig retrovirus infects human cells to who sets trial principles. The results narrowed the next question without closing it.

1997
Pig retrovirus infects human cells
Researchers showed porcine endogenous retrovirus could infect human cells in vitro, elevating population-level infection concerns.
201520203 events0 shown

Preclinical Barriers Begin Falling

Preclinical Barriers Begin Falling moved the field from crispr disables 62 perv copies to life-supporting hearts pass six months. The results narrowed the next question without closing it.

2021207512 events4 shown

Humans Enter Controlled Trials

Humans Enter Controlled Trials moved the field from gene-edited kidney enters human body to expand primary completion target. The results narrowed the next question without closing it.

2021
Gene-edited kidney enters human bodyExperiment
An alpha-Gal-knockout pig kidney made urine without hyperacute rejection during a 54-hour brain-dead-body study.
2023
Decedent kidney runs 61 days
A single-edit pig kidney functioned for 61 days; dense sampling later mapped about 5,100 human and pig genes during rejection.
2023
Second pig heart rejected
Lawrence Faucette died 40 days after transplant; the heart performed well for one month before showing rejection.
2024
Combined transplant ends at 47 days
Lisa Pisano's single-edit pig kidney was removed after 47 days following hypotension-related damage; she died six weeks later.
2024
Looney reaches 130 days
Towana Looney lived dialysis-free for 130 days; acute rejection followed reduced immunosuppression for an unrelated infection.
2025
First controlled kidney trial startsDeployment
EXPAND transplanted its first participant and opened a six-person first cohort, with 24-week safety and efficacy endpoints.
2026
Controlled trials, sparse outcomesDeploymentWe are here
EXPAND targets 50 participants, but no cohort-level 24-week survival distribution has yet been posted; 271 days remains the completed record.
2028
EXPAND primary completion targetDeploymentTarget
The 50-participant EXPAND registry record estimates primary completion in October 2028; this is scheduled, not achieved.
207520751 event0 shown

Events outside the declared eras

Events outside the declared eras begins with lifetime surveillance horizon. The result established the next question for the field.

2075
Lifetime surveillance horizonDeploymentTarget
EXPAND lists study completion in 2075 because recipients require lifelong graft and zoonotic-infection follow-up.
03 · The data behind the verdict

Why the meters read the way they do

The learning curves and comparisons that justify each threshold's percentage. Every series is measured, with the source event linked in the timeline above.

The survival staircase

The climb to a line

271 daysbest observed
This carries forward the candidate node's recommended metric. Values are individual cases, not a survival curve: compassionate-use recipients differed sharply in illness, donor edits and immunosuppression. Stewart's 250-day point is a published minimum while ongoing, not a final outcome. The one-year line is an editorial near-term goal; the candidate node's ten-year mature benchmark is deliberately not plotted because it is aspirational, not a dated forecast. Brain-dead-body experiments are excluded because they cannot establish recipient survival or durable clinical independence from dialysis. The best observed case is 271 days, leaving 94 days to the 365-day goal.Initial one-year durability · 365 daysDialysis-free functional pig-kidney graft survival in living recipients · daysLiving-recipient case0197.1394.2Richard Slayman; 52 days with the transplant before recipient death: 52 days (2024)522024Lisa Pisano; graft explanted after hypotension-related damage: 47 days (2024)472024Towana Looney; graft explanted after acute rejection: 130 days (2025)1302025Tim Andrews; graft explanted after declining function: 271 days (2025)2712025Bill Stewart; at least 250 days and ongoing at the last public update (right-censored): 250 days (2026)250202694 days lefteach bar = one living-recipient case

NOTE — This carries forward the candidate node's recommended metric. Values are individual cases, not a survival curve: compassionate-use recipients differed sharply in illness, donor edits and immunosuppression. Stewart's 250-day point is a published minimum while ongoing, not a final outcome. The one-year line is an editorial near-term goal; the candidate node's ten-year mature benchmark is deliberately not plotted because it is aspirational, not a dated forecast. Brain-dead-body experiments are excluded because they cannot establish recipient survival or durable clinical independence from dialysis.

Observation windows expanded from 54 hours to 61 days, enabling richer physiology and rejection sampling, but these models are not clinical survival evidence.
Observation windows expanded from 54 hours to 61 days, enabling richer physiology and rejection sampling, but these models are not clinical survival evidence.010203040506070Brain-dead human kidney-study duration · daysYear202120222023Brain-dead human kidney-study duration: 2.3 days (2021)Brain-dead human kidney-study duration: 3.2 days (2022)Brain-dead human kidney-study duration: 7 days (2023)Brain-dead human kidney-study duration: 61 days (2023)61 days
NOTE — Observation windows expanded from 54 hours to 61 days, enabling richer physiology and rejection sampling, but these models are not clinical survival evidence.
The 945-day heterotopic result did not support life; the more stringent orthotopic, life-supporting model reached 195 days, so this is a model comparison, not a declining trend.
The 945-day heterotopic result did not support life; the more stringent orthotopic, life-supporting model reached 195 days, so this is a model comparison, not a declining trend.02004006008001,000Selected pig-heart survival in baboons · daysYear20162018Selected pig-heart survival in baboons: 945 days (2016)Selected pig-heart survival in baboons: 195 days (2018)195 days
NOTE — The 945-day heterotopic result did not support life; the more stringent orthotopic, life-supporting model reached 195 days, so this is a model comparison, not a declining trend.
Engineering breadth increased, but edit count is not a performance score: competing clinical programs still test 10-edit and 69-edit kidneys.
Engineering breadth increased, but edit count is not a performance score: competing clinical programs still test 10-edit and 69-edit kidneys.010203040506070Maximum donor-pig genome modifications used in a human kidney study · genome modificationsYear202120222024Maximum donor-pig genome modifications used in a human kidney study: 1 genome modifications (2021)Maximum donor-pig genome modifications used in a human kidney study: 10 genome modifications (2022)Maximum donor-pig genome modifications used in a human kidney study: 69 genome modifications (2024)69 genome modifications
NOTE — Engineering breadth increased, but edit count is not a performance score: competing clinical programs still test 10-edit and 69-edit kidneys.
  • People waiting for a kidney90400 people
  • Kidney transplants performed in 202427759 transplants
COMPARISON — The U.S. kidney waiting list is more than three times annual kidney transplant volume.
  • Completed record271 days
  • Initial durability goal365 days
COMPARISON — The completed living-recipient record has covered about three quarters of the first one-year durability target.
  • eGenesis EGEN-278469 genome modifications
  • United Therapeutics UKidney10 gene edits
COMPARISON — Two kidney programs are testing radically different genome-engineering strategies; more edits are not proven better.
  • Heterotopic baboon record945 days
  • Orthotopic life-supporting record195 days
COMPARISON — A non-life-supporting heart model lasted far longer than the stricter replacement-heart model.
04 · What it unlocks

If the remaining tests pass

Downstream capabilities, drawn dashed because they depend on results not yet in.

XenotransplantAn expandable organ supplyPurpose-bred donor herds could replace today's dependence on scarce, unpredictable human donations.Earlier treatment of organ failurePatients could receive a planned transplant before years of dialysis or terminal decline make surgery riskier.Bridges to human transplantsEven initially time-limited pig organs could buy months or years until a matched human organ becomes available.A replaceable organ supplyOn-demand transplant organs remove one of the hard limits on a long, healthy life.
05 · Sources

Where every number comes from

  1. International Xenotransplantation Association 2025 position paperpmc.ncbi.nlm.nih.gov
  2. FDA xenotransplantation guidancefda.gov
  3. ClinicalTrials.gov EXPAND record NCT06878560clinicaltrials.gov
  4. NYU Langone EXPAND trial launchnyulangone.org
  5. AP report on the 271-day completed recordapnews.com
  6. eGenesis EGEN-2784 IND clearance and patient updateegenesisbio.com
  7. NYU Langone 61-day immune-mapping studynyulangone.org
  8. University of Maryland lessons from the first pig-heart recipientmedschool.umaryland.edu
  9. Science paper on multiplex PERV inactivationpubmed.ncbi.nlm.nih.gov
  10. Historical review of cross-species organ transplantationpmc.ncbi.nlm.nih.gov